Improving visual perception in people with schizophrenia
Visual Remediation in Schizophrenia
This study is looking at ways to help people with schizophrenia improve their vision skills, like seeing contrasts and organizing what they see, so they can have an easier time in daily life and social situations.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10682448 on NIH RePORTER |
What this research studies
This research investigates how visual perception impairments in individuals with schizophrenia can be addressed through a targeted intervention. The approach focuses on enhancing specific visual functions, such as contrast sensitivity and perceptual organization, which are crucial for daily living and social interactions. By utilizing techniques from cognitive rehabilitation, the study aims to determine the most effective methods for improving these visual skills, potentially leading to better cognitive and functional outcomes for participants. The research will involve testing various interventions to identify which ones yield the best results in visual remediation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with schizophrenia who experience visual perception impairments.
Not a fit: Patients without schizophrenia or those who do not exhibit visual perception impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the visual perception abilities of patients with schizophrenia, enhancing their daily functioning and quality of life.
How similar studies have performed: While visual remediation for schizophrenia is a relatively novel area, initial studies suggest that visual perceptual learning can lead to meaningful improvements, indicating potential for success.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Silverstein, Steven M — University of Rochester
- Study coordinator: Silverstein, Steven M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.